Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
uniQure N.V.
Director
CG Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | CG Oncology Inc. | Option exercise | +1,000 | $0.60 | $600 |
| Jul 15, 2026 | CG Oncology Inc. | Open-market sale | −1,000 | $71.17 | $71,170 |
| Jun 24, 2026 | CG Oncology Inc. | Option exercise | +5,000 | $0.60 | $3,000 |
| Jun 24, 2026 | CG Oncology Inc. | Open-market sale | −5,000 | $70.00 | $350,000 |
| Jun 22, 2026 | CG Oncology Inc. | Option exercise | +5,000 | $0.60 | $3,000 |
| Jun 22, 2026 | CG Oncology Inc. | Open-market sale | −5,000 | $65.00 | $325,000 |
| Jun 11, 2026 | uniQure N.V. | Open-market sale | −1,993 | $27.06 | $53,931 |
| Jun 10, 2026 | uniQure N.V. | Grant or award | +7,550 | — | — |
| Jun 4, 2026 | CG Oncology Inc. | Option exercise | +1,000 | $0.60 | $600 |
| Jun 4, 2026 | CG Oncology Inc. | Open-market sale | −1,000 | $54.50 | $54,500 |
| Nov 17, 2025 | CG Oncology Inc. | Option exercise | +1,000 | $0.60 | $600 |
| Nov 17, 2025 | CG Oncology Inc. | Open-market sale | −1,000 | $41.43 | $41,430 |
| Oct 13, 2025 | CG Oncology Inc. | Option exercise | +1,000 | $0.60 | $600 |
| Oct 13, 2025 | CG Oncology Inc. | Open-market sale | −1,000 | $43.25 | $43,250 |
| Sep 30, 2025 | CG Oncology Inc. | Option exercise | +5,000 | $0.60 | $3,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.